elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28543732-1E63305D-2126-4AAE-9894-B1C6D301B33A
Q28543732-1E63305D-2126-4AAE-9894-B1C6D301B33A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28543732-1E63305D-2126-4AAE-9894-B1C6D301B33A
Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infection
P407
Q28543732-1E63305D-2126-4AAE-9894-B1C6D301B33A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28543732-1E63305D-2126-4AAE-9894-B1C6D301B33A
rank
NormalRank
type
BestRank
Statement
P407
English